These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16888434)

  • 1. Continuous infusion of coagulation factors: current opinion.
    Batorova A; Martinowitz U
    Curr Opin Hematol; 2006 Sep; 13(5):308-15. PubMed ID: 16888434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous infusion of coagulation factor products.
    Stachnik JM; Gabay MP
    Ann Pharmacother; 2002 May; 36(5):882-91. PubMed ID: 11978168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition considerations for extended half-life factor products.
    Croteau SE; Neufeld EJ
    Haemophilia; 2015 May; 21(3):285-288. PubMed ID: 25855484
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous infusion of coagulation factors.
    Batorova A; Martinowitz U
    Haemophilia; 2002 May; 8(3):170-7. PubMed ID: 12010406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience.
    Campbell PJ; Rickard KA
    Aust N Z J Med; 1998 Aug; 28(4):440-5. PubMed ID: 9777111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of pumps for continuous infusion of coagulation factor concentrates: what are the options?
    Martinowitz U; Schulman S
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S27-33. PubMed ID: 8735794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium.
    Mauser-Bunschoten EP; de Goede-Bolder A; Wielenga JJ; Levi M; Peerlinck K
    Neth J Med; 1998 Dec; 53(6):249-55. PubMed ID: 9883002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous infusion of coagulation factor concentrates during intensive treatment.
    Holme PA; Tjønnfjord GE; Batorova A
    Haemophilia; 2018 Jan; 24(1):24-32. PubMed ID: 28873263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and assessment of clinical trials on continuous infusion.
    Schulman S; Martinowitz U
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S7-9. PubMed ID: 8735790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
    Monahan PE; Aledort LM;
    Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needles and needleless devices for infusion of anti-haemophilic factor concentrate: impact on protein structure and function.
    Prabhu S; Kazarian T; Hakobyan N; Jabbar A; Dunham T; Valentino LA
    Haemophilia; 2006 Jan; 12(1):58-61. PubMed ID: 16409176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic infusion regimens in the management of hemophilia.
    Ljung RC
    Thromb Haemost; 1999 Aug; 82(2):525-30. PubMed ID: 10605746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose and outcome of care in haemophilia--how do we define cost-effectiveness?
    Fischer K; Van den Berg HM; Thomas R; Kumar S; Poonnoose P; Viswabandya A; Mathews V; Kavitha ML; Bhattacharji S; Srivastava A
    Haemophilia; 2004 Oct; 10 Suppl 4():216-20. PubMed ID: 15479401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion therapy in haemophilia.
    Varon D; Martinowitz U
    Haemophilia; 1998 Jul; 4(4):431-5. PubMed ID: 9873771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regimens of factor VIII administration--continuous infusion vs. bolus.
    Berntorp E
    Haematologica; 2000 Oct; 85(10 Suppl):69-71; discussion 71-2. PubMed ID: 11187875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary prophylaxis with factor IX concentrates: continuous infusion.
    Morfini M
    Blood Transfus; 2008 Sep; 6 Suppl 2(Suppl 2):s21-5. PubMed ID: 19105506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous infusion.
    Schulman S
    Haemophilia; 2003 Jul; 9(4):368-75. PubMed ID: 12828670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis and continuous infusion for hemophilia: can we afford it?
    Aledort LM; Bohn RL
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S35-7. PubMed ID: 8735795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of pharmacologic options for the treatment of persons with hemophilia.
    Franchini M; Mannucci PM
    Expert Opin Drug Saf; 2016 Oct; 15(10):1391-400. PubMed ID: 27367551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous infusion of recombinant activated factor VII during and after elbow arthroplasty in a hemophilia A patient with inhibitors].
    Nakamura M; Terashima K; Takashima Y; Amano K; Horikoshi Y; Mimaya J
    Rinsho Ketsueki; 2002 Mar; 43(3):183-8. PubMed ID: 11979750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.